So phage therapy won’t have the weakness of antibiotics (some things are resistant) because it isn’t using one existing general attack, but instead creates a new set of specialized attacks/tactics.
Yes. It’s a toolkit that allow more targeted attacks on bacteria then antibiotics provide. This means that you get the benefits of a more targeted intervention but you regulation that allows you to provide more targeted interventions and the analytics to target your interventions.
So phage therapy won’t have the weakness of antibiotics (some things are resistant) because it isn’t using one existing general attack, but instead creates a new set of specialized attacks/tactics.
Yes. It’s a toolkit that allow more targeted attacks on bacteria then antibiotics provide. This means that you get the benefits of a more targeted intervention but you regulation that allows you to provide more targeted interventions and the analytics to target your interventions.